Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lianhua Yuping granules
- Development stage
- Unknown
- Lead developer
- Yiling Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Lianhua Yuping granules is a Traditional Chinese Medicine (TCM) candidate developed by Shijiazhuang Yiling Pharmaceutical for the treatment of the common cold, specifically targeting the "qi deficiency" pattern. The formulation likely integrates the anti-infective properties of the "Lianhua" brand (traditionally associated with herbs like *Lonicera japonica* and *Forsythia suspensa*) with the immune-strengthening effects of the "Yu Ping Feng" formula (typically comprising *Astragalus membranaceus*, *Atractylodes macrocephala*, and *Saposhnikovia divaricata*). It is currently undergoing Phase II clinical evaluation in China to determine its efficacy and safety in reducing cold symptoms and preventing complications in vulnerable populations.
- Brand names
- Lianhua Yuping granules
- Other names
- Lianhua Yuping Keli
Beyond the preview
Go deeper on Lianhua Yuping granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lianhua Yuping granules.